Drug intelligence / Profile preview

perfluorobutylpentane

Development stage
Unknown
Lead developer
Novaliq
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Perfluorobutylpentane (PFBP), also known as F4H5, is a semifluorinated alkane (SFA) small molecule that serves as a high-performance drug delivery vehicle and excipient in ophthalmic medicine. Developed by Novaliq, it is the core component of the EyeSol technology platform and functions as the water-free, preservative-free vehicle in VEVYE (cyclosporine ophthalmic solution 0.1%) for the treatment of dry eye disease. PFBP is chemically inert, amphiphilic, and possesses an exceptionally low surface tension, which allows it to dissolve hydrophobic active pharmaceutical ingredients and spread rapidly across the ocular surface without causing the blurred vision or stinging typically associated with aqueous formulations. Beyond its role as a vehicle, PFBP has been utilized in vitreoretinal surgery as a heavy liquid for temporary intraocular tamponade and has been investigated for use in pulmonary drug delivery systems.

Other names
1-(perfluorobutyl)pentane5-(perfluorobutyl)pentanesemifluorinated alkane F4H5

Beyond the preview

Go deeper on perfluorobutylpentane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on perfluorobutylpentane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call